Ramkumar V, Mukherjea D, Dhukhwa A, Rybak LP (2021) Oxidative stress and inflammation caused by cisplatin ototoxicity. Antioxidants 10(12):1919
Article CAS PubMed PubMed Central Google Scholar
Small W, Bacon MA, Bajaj A, Chuang LT, Gaffney DK (2017) Cervical cancer: a global health crisis. Obstet Gynecol Surv 72(11):654–655
He YZ, Zheng ZW, Liu C, Li W, Zhao LP, Nie GH, Li HW (2022) Inhibiting DNA methylation alleviates cisplatin- induced hearing loss by decreasing oxidative stress-induced mitochondria-dependent apoptosis via the LRP1-PI3K/AKT pathway. Acta Pharmaceutica Sinica B 12(3):1305–1321
Article CAS PubMed Google Scholar
Karasawa T, Steyger PS (2015) An integrated view of cisplatin-induced nephrotoxicity and ototoxicity. Toxicol Lett 237(3):219–227
Article CAS PubMed PubMed Central Google Scholar
Paken J, Govender CD, Pillay M, Sewram V (2022) Cisplatin-associated ototoxicity: perspectives from a single institution cervical cancer cohort and implications for developing a locally responsive monitoring programme in a public healthcare setting. BMC Health Serv Res 22(1):1–14
Tang Q, Wang X, Jin H, Mi Y, Zou Z (2021) Cisplatin-induced ototoxicity: updates on molecular mechanisms and otoprotective strategies. Eur J Pharm Biopharm 163(7):60–71
Article CAS PubMed Google Scholar
Breglio AM, Rusheen AE, Shide ED, Fernandez KA, Spielbauer KK, McLachlin KM, Hall MD, Amable L, Cunningham LL (2017) Cisplatin is retained in the cochlea indefinitely following chemotherapy. Nat Commun 8(1):1654
Article PubMed PubMed Central Google Scholar
Wang WL, Chen EF, Ding XR, Lu PH, Chen JW, Ma PW, Lu LJ (2022) N-acetylcysteine protect inner hair cells from cisplatin by alleviated celluar oxidative stress and apoptosis. Toxicol In Vitro 81:105354
Article CAS PubMed Google Scholar
Gentilin E, Simoni E, Candito M, Cazzador D, Astolfi L (2019) Cisplatin-induced ototoxicity: updates on molecular targets. Trends Mol Med 25(12):1123–1132
Article CAS PubMed Google Scholar
Zallocchi M, Hati S, Xu Z, Hausman W, Zuo J (2021) Characterization of quinoxaline derivatives for protection against iatrogenic-induced hearing loss. JCI Insight 6(5):e141561
Article PubMed PubMed Central Google Scholar
Rybak LP (2007) Mechanisms of cisplatin ototoxicity and progress in otoprotection. Curr Opin Otolaryngol Head Neck Surg 15(5):364–369
Yu D, Gu J, Chen Y, Kang W, Wu H (2020) Current strategies to combat cisplatin-induced ototoxicity. Front Pharmacol 11:999
Article CAS PubMed PubMed Central Google Scholar
He FA, Huang XT, Wei GK, Lin XR, Zhang WJ, Zhuang W, He WH, Zhan T, Hu H, Yang HD (2022) Regulation of ACSL4-catalyzed lipid peroxidation process resists cisplatin ototoxicity. Oxid Med Cell Longev 3080263
Mukherjea D, Dhukhwa A, Sapra A, Bhandari P, Rybak L (2020) Strategies to reduce the risk of platinum containing antineoplastic drug-induced ototoxicity. Expert Opin Drug Metab Toxicol 16(10):965–982: PMID:32757852
Article CAS PubMed PubMed Central Google Scholar
Bhatta P, Dhukhwa A, Sheehan K, Al Aameri RFH, Borse V, Ghosh S, Sheth S, Mamillapalli C, Rybak L, Ramkumar V et al (2019) Capsaicin protects against cisplatin ototoxicity by changing the STAT3/STAT1 ratio and activating cannabinoid (CB2) receptors in the cochlea. Sci Rep 9(1):4131
Article PubMed PubMed Central Google Scholar
Kim HJ, Oh GS, Lee JH, Lyu AR, Ji HM, Lee SH, Song J, Park SJ, You YO, Sul JD (2011) Cisplatin ototoxicity involves cytokines and STAT6 signaling network. Cell Res 21(6):13
So H, Kim H, Kim Y, Kim E, Pae HO, Chung HT, Kim HJ, Kwon KB, Lee KM, Lee HY et al (2008) Evidence that cisplatin-induced auditory damage is attenuated by downregulation of pro-inflammatory cytokines via Nrf2/HO-1. Jaro-Journal of the Association for Research in Otolaryngology 9(3):290–306
Article PubMed Central Google Scholar
Volker N, Kwang P, Rahul J, Arwa K, Ryan AF (2017) An antioxidant screen identifies candidates for protection of cochlear hair cells from gentamicin toxicity. Front Cell Neurosci 11:242
Tian CJ, Kim YJ, Kim SW, Lim HJ, Kim YS, Choung YH (2013) A combination of cilostazol and ginkgo biloba extract protects against cisplatin-induced cochleo-vestibular dysfunction by inhibiting the mitochondrial apoptotic and ERK pathways. J Micro/Nanolithogr MEMS MOEMS 4(2):e509
Tan XD, Zhou YJ, Agarwal A, Lim M, Xu YY, Zhu YM, O’Brien J, Tran E, Zheng J, Gius D et al (2020) Systemic application of honokiol prevents cisplatin ototoxicity without compromising its antitumor effect. Am J Cancer Res 10(12):4416
CAS PubMed PubMed Central Google Scholar
Rolland V, Meyer F, Guitton MJ, Bussières R, Philippon D, Bairati I, Leclerc M, Côté M (2019) A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancer. J Otolaryngol Head Neck Surg 48(1):4
Article PubMed PubMed Central Google Scholar
Sarafraz Z, Ahmadi A, Daneshi A (2018) Transtympanic injections of N-acetylcysteine and dexamethasone for prevention of cisplatin-induced ototoxicity: double blind randomized clinical trial. International Tinnitus Journal 22(1):40
Freyer DR, Chen L, Krailo MD, Knight K, Villaluna D, Bliss B, Pollock BH, Ramdas J, Lange B, Van Hoff D (2017) Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial. Lancet Oncology 18(1):63
Article CAS PubMed Google Scholar
Brock PR, Maibach R, Childs M, Rajput K, Neuwelt EA (2018) Sodium thiosulfate for protection from cisplatin-induced hearing loss. N Engl J Med 378(25):191
Kros CJ, Steyger PS (2019) Aminoglycoside- and cisplatin-induced ototoxicity: mechanisms and otoprotective strategies. Cold Spring Harbor Laboratory Press 9(11):a033548
Abada P (2011) SB H: Regulation of cisplatin cytotoxicity by cu influx transporters. Metal Based Drugs 2010:317581
Kros CJ, Steyger PS (2019) Aminoglycoside- and cisplatin-induced ototoxicity: mechanisms and otoprotective strategies. Cold Spring Harb Perspect Med 9(11):a033548
Article CAS PubMed PubMed Central Google Scholar
Ciarimboli G, Deuster D, Knief A, Sperling M, Holtkamp M, Edemir B, Pavenstädt H, Lanvers-Kaminsky C, Zehnhoff-Dinnesen AA, Schinkel AH et al (2010) Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions. Am J Pathol 176(3):1169–1180
Article CAS PubMed PubMed Central Google Scholar
Ingersoll MA, Malloy EA, Caster LE, Holland EM, Teitz T (2020) BRAF inhibition protects against hearing loss in mice. Sci Adv 6(49):eabd0561
CAS PubMed PubMed Central Google Scholar
Kitcher SR, Kirkwood NK, Camci ED, Wu P, Gibson RM, Redila VA, Simon JA, Rubel EW, Raible DW, Richardson GP et al (2019) ORC-13661 protects sensory hair cells from aminoglycoside and cisplatin ototoxicity. Jci Insight 4(15):e126764
Article PubMed PubMed Central Google Scholar
Li M, Liu JW, Liu D, Duan XC, Zhang QC, Wang DW, Zheng QY, Bai XH, Lu ZM (2021) Naringin attenuates cisplatin- and aminoglycoside-induced hair cell injury in the zebrafish lateral line via multiple pathways. J Cell Mol Med 25(2):975–989
Article CAS PubMed Google Scholar
Rocha-Sanchez SM, Fuson O, Tarang S, Goodman L, Pyakurel U, Liu HZ, He DZ, Zallocchi M (2019) Quinoxaline protects zebrafish lateral line hair cells from cisplatin and aminoglycosides damage (vol 8, 15119, 2018). Sci Rep 8(1):15119
Fernandes VT, Lin VYW (2014) Development of an ototoxicity model in the adult CBA/CaJ mouse and determination of a golden window of corticosteroid intervention for otoprotection. Journal of Otolaryngology-Head & Neck Surgery 43(1):12
Comments (0)